Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile - PubMed (original) (raw)
. 2002 Feb 1;34(3):346-53.
doi: 10.1086/338260. Epub 2001 Dec 17.
Affiliations
- PMID: 11774082
- DOI: 10.1086/338260
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile
Lorraine Kyne et al. Clin Infect Dis. 2002.
Abstract
A total of 271 patients were prospectively followed up to determine whether patients whose hospital stay is complicated by diarrhea due to Clostridium difficile experience differences in cost and length of stay and survival rates when compared with patients whose stay is not complicated by C. difficile-associated diarrhea. Forty patients (15%) developed nosocomial C. difficile-associated diarrhea. These patients incurred adjusted hospital costs of 3669−−thatis,543669--that is, 54% (95% confidence interval [CI], 17%-103%)--higher than patients whose course was not complicated by C. difficile-associated diarrhea. The extra length of stay attributable to C. difficile-associated diarrhea was 3.6 days (95% CI, 1.5-6.2). C. difficile-associated diarrhea was not associated with excess 3-month or 1-year mortality after adjustment for age, comorbidity, and disease severity. On the basis of the findings of this study, a conservative estimate of the cost of this disease in the United States exceeds 3669−−thatis,541.1 billion per year.
Similar articles
- Costs of nosocomial Clostridium difficile-associated diarrhoea.
Vonberg RP, Reichardt C, Behnke M, Schwab F, Zindler S, Gastmeier P. Vonberg RP, et al. J Hosp Infect. 2008 Sep;70(1):15-20. doi: 10.1016/j.jhin.2008.05.004. Epub 2008 Jul 7. J Hosp Infect. 2008. PMID: 18602185 - Nosocomial diarrhea and Clostridium Difficile associated diarrhea in a Turkish University Hospital.
Ergen EK, Akalin H, Yilmaz E, Sinirtaş M, Alver O, Heper Y, Ozakin C, Bakker D, Ener B, Mistik R, Helvaci S, Kuijper EJ. Ergen EK, et al. Med Mal Infect. 2009 Jun;39(6):382-7. doi: 10.1016/j.medmal.2009.02.001. Epub 2009 Mar 9. Med Mal Infect. 2009. PMID: 19269761 - Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.
McFarland LV, Clarridge JE, Beneda HW, Raugi GJ. McFarland LV, et al. Clin Infect Dis. 2007 Nov 1;45(9):1141-51. doi: 10.1086/522187. Epub 2007 Sep 26. Clin Infect Dis. 2007. PMID: 17918075 - [Hospital-acquired clostridium difficile-associated diarrhea].
Hu YJ. Hu YJ. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Oct;30(5):618-21. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008. PMID: 19024399 Review. Chinese. - Recognizing and managing Clostridium difficile-associated diarrhea.
Miller JM, Walton JC, Tordecilla LL. Miller JM, et al. Medsurg Nurs. 1998 Dec;7(6):348-9, 352-6. Medsurg Nurs. 1998. PMID: 10036439 Review.
Cited by
- Economic cost of a case of diarrhoea in Uvira, Democratic Republic of the Congo: A cost of illness study.
Katana PV, Malembaka EB, Bugeme PM, Saidi JM, Cumming O, Gallandat K, Ross I. Katana PV, et al. PLoS Negl Trop Dis. 2024 Oct 28;18(10):e0011934. doi: 10.1371/journal.pntd.0011934. eCollection 2024 Oct. PLoS Negl Trop Dis. 2024. PMID: 39466843 Free PMC article. - Gut Microbiota and New Microbiome-Targeted Drugs for Clostridioides difficile Infections.
Lee A, Yoo JS, Yoon EJ. Lee A, et al. Antibiotics (Basel). 2024 Oct 20;13(10):995. doi: 10.3390/antibiotics13100995. Antibiotics (Basel). 2024. PMID: 39452261 Free PMC article. Review. - A commensal protozoan attenuates Clostridioides difficile pathogenesis in mice via arginine-ornithine metabolism and host intestinal immune response.
Yang H, Wu X, Li X, Zang W, Zhou Z, Zhou Y, Cui W, Kou Y, Wang L, Hu A, Wu L, Yin Z, Chen Q, Chen Y, Huang Z, Wang Y, Gu B. Yang H, et al. Nat Commun. 2024 Apr 2;15(1):2842. doi: 10.1038/s41467-024-47075-0. Nat Commun. 2024. PMID: 38565558 Free PMC article. - Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients.
Huang CH, Tseng YH, Tsai WS, Su CC, Cheng CL, Kao Yang YH, Chang YC, Liu YH. Huang CH, et al. Infect Dis Ther. 2024 Feb;13(2):373-383. doi: 10.1007/s40121-024-00922-5. Epub 2024 Jan 30. Infect Dis Ther. 2024. PMID: 38286955 Free PMC article. - Molecular characteristics and phylogenetic analysis of Clostridium perfringens from different regions in China, from 2013 to 2021.
Zhong JX, Zheng HR, Wang YY, Bai LL, Du XL, Wu Y, Lu JX. Zhong JX, et al. Front Microbiol. 2023 Jul 6;14:1195083. doi: 10.3389/fmicb.2023.1195083. eCollection 2023. Front Microbiol. 2023. PMID: 37485514 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical